Fuller & Thaler Asset Management Inc. Has $74.60 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Fuller & Thaler Asset Management Inc. decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,215,433 shares of the company's stock after selling 729,203 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 1.89% of Option Care Health worth $74,598,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of OPCH. JPMorgan Chase & Co. increased its stake in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after acquiring an additional 344,875 shares during the last quarter. Graypoint LLC acquired a new stake in shares of Option Care Health in the fourth quarter valued at about $1,161,000. Charles Schwab Investment Management Inc. grew its stake in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. raised its position in shares of Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after purchasing an additional 18,992 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in Option Care Health in the fourth quarter valued at $327,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on OPCH shares. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Monday, April 21st. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $33.75.

Option Care Health Stock Performance

Option Care Health stock traded down $2.26 during midday trading on Tuesday, reaching $30.72. 2,511,418 shares of the company's stock were exchanged, compared to its average volume of 1,784,376. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The firm has a market cap of $5.04 billion, a price-to-earnings ratio of 25.71, a P/E/G ratio of 2.30 and a beta of 1.07. The stock's 50-day simple moving average is $33.37 and its 200 day simple moving average is $28.78. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.